In this context, it has been demonstrated that TRAIL supported the conversion into a highly metastatic phenotype in pancreatic carcinomas by the induction of proinflammatory cytokines [29]. This evidence concerns the gene TNFSF10 and exocrine pancreatic carcinoma.